Marshall Wace, LLP Bristol Myers Squibb CO Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Marshall Wace, LLP holds 868,109 shares of BMY stock, worth $50.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

868,109

Previous 255,730 239.46%

Holding current value

$50.1 Million

Previous $10.6 Million 323.01%

% of portfolio

0.06%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $24.3 Million - $31.7 Million	612,379 Added 239.46%	868,109 $44.9 Million
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $24.9 Million - $32.8 Million	-618,454 Reduced 70.75%	255,730 $10.6 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $41.9 Million - $47.6 Million	874,184 New	874,184 $47.4 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $92.3 Million - $103 Million	-1,595,177 Reduced 82.46%	339,352 $19.7 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $123 Million - $137 Million	1,934,529 New	1,934,529 $124 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $4.36 Million - $5.17 Million	63,721 New	63,721 $4.58 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $4.18 Million - $4.61 Million	-57,620 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $3.08 Million - $3.69 Million	50,100 Added 666.22%	57,620 $4.21 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $73,044 - $85,152	1,362 Added 22.12%	7,520 $469,000
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $3.05 Million - $3.57 Million	-51,576 Reduced 89.33%	6,158 $365,000
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $42.6 Million - $46.4 Million	-688,291 Reduced 92.26%	57,734 $3.86 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $28 Million - $31.5 Million	-471,700 Reduced 38.74%	746,025 $47.1 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $48.9 Million - $55.5 Million	847,514 Added 228.93%	1,217,725 $75.5 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $4.31 Million - $4.78 Million	-75,075 Reduced 16.86%	370,211 $22.3 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $23.8 Million - $27.8 Million	433,882 Added 3804.65%	445,286 $26.2 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $1.31 Million - $1.9 Million	-28,177 Reduced 71.19%	11,404 $636,000
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $3.46 Million - $4.51 Million	-70,306 Reduced 63.98%	39,581 $2.54 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $1.43 Million - $1.69 Million	33,361 Added 43.59%	109,887 $5.57 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $2.7 Million - $2.98 Million	-60,463 Reduced 44.14%	76,526 $3.47 Million
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $28.5 Million - $33.9 Million	-630,878 Reduced 82.16%	136,989 $6.54 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $4.86 Million - $6.31 Million	-99,754 Reduced 11.5%	767,867 $39.9 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $7.76 Million - $8.75 Million	140,539 Added 19.33%	867,621 $53.9 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $34.1 Million - $42.5 Million	674,457 Added 1281.63%	727,082 $40.2 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $15 Million - $17.3 Million	-250,968 Reduced 82.67%	52,625 $3.33 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $12.9 Million - $14.1 Million	215,335 Added 243.98%	303,593 $18.6 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $4.87 Million - $5.63 Million	88,258	88,258 $5.65 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Bristol Myers Squibb CO Transaction History